803 reports of this reaction
3.1% of all DOCOSANOL reports
#5 most reported adverse reaction
INCORRECT DRUG ADMINISTRATION DURATION is the #5 most commonly reported adverse reaction for DOCOSANOL, manufactured by Haleon US Holdings LLC. There are 803 FDA adverse event reports linking DOCOSANOL to INCORRECT DRUG ADMINISTRATION DURATION. This represents approximately 3.1% of all 26,055 adverse event reports for this drug.
Patients taking DOCOSANOL who experience incorrect drug administration duration should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INCORRECT DRUG ADMINISTRATION DURATION is moderately reported among DOCOSANOL users, representing a notable but not dominant share of adverse events.
In addition to incorrect drug administration duration, the following adverse reactions have been reported for DOCOSANOL:
The following drugs have also been linked to incorrect drug administration duration in FDA adverse event reports:
INCORRECT DRUG ADMINISTRATION DURATION has been reported as an adverse event in 803 FDA reports for DOCOSANOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
INCORRECT DRUG ADMINISTRATION DURATION accounts for approximately 3.1% of all adverse event reports for DOCOSANOL, making it a notable side effect.
If you experience incorrect drug administration duration while taking DOCOSANOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.